Currently there are no indications for use of rhIGF-1 in diabetes treatment, but there is ongoing interest in exploiting IGF-dependent and -independent actions of IGFBPs, especially IGFBP -1 and -2, to influence insulin sensitivity [82]. This evidence concerns the gene IGF1 and diabetes mellitus.